Literature DB >> 8507212

Expressions of matrilysin and stromelysin in human glioma cells.

A Nakano1, E Tani, K Miyazaki, J Furuyama, T Matsumoto.   

Abstract

Production of matrilysin and stromelysin by five human glioma cell lines was investigated by Northern blot and immunoblot analyses. Four cell lines constitutively produced matrilysin. Its production was stimulated by phorbol-12-myristate-13-acetate (PMA) in two cell lines and by transforming growth factor-beta 1 (TGF-beta 1) in two other cell lines. Stromelysin transcript was constitutively expressed in only two cell lines, but enhanced or induced by PMA in four cell lines. These results suggest that these enzymes, especially matrilysin, may be involved in the invasive growth of neoplastic glial cells.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8507212     DOI： 10.1006/bbrc.1993.1515

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Multi-agent cytostatic treatment of 'low-grade' gliomas.

Authors:  M E Linskey
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Authors:  W Wick; M Platten; M Weller
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.

Authors:  T Nakagawa; T Kubota; M Kabuto; N Fujimoto; Y Okada
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

4.  Expression of stromelysin 1 in human astrocytoma cell lines.

Authors:  K Matsuzawa; K Fukuyama; P B Dirks; S Hubbard; M Murakami; L E Becker; J T Rutka
Journal:  J Neurooncol       Date:  1996-12       Impact factor: 4.130

5.  High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.

Authors:  P A Forsyth; T D Laing; A W Gibson; N B Rewcastle; P Brasher; G Sutherland; R N Johnston; D R Edwards
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 6.  Matrix degrading metalloproteinases.

Authors:  B W Ennis; L M Matrisian
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.

Authors:  K Lampert; U Machein; M R Machein; W Conca; H H Peter; B Volk
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1.

Authors:  Tiziana Piepoli; Cemile Jakupoglu; Wenli Gu; Elena Lualdi; Blanca Suarez-Merino; Pietro L Poliani; Maria Grazia Cattaneo; Barbara Ortino; Dorota Goplen; Jian Wang; Rosa Mola; Francesca Inverardi; Carolina Frassoni; Rolf Bjerkvig; Ortrud Steinlein; Lucia M Vicentini; Oliver Brüstle; Gaetano Finocchiaro
Journal:  Neuro Oncol       Date:  2006-03-02       Impact factor: 12.300

9.  Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Authors:  G Perides; R A Asher; M W Lark; W S Lane; R A Robinson; A Bignami
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

Authors:  S Mohanam; S W Wang; A Rayford; M Yamamoto; R Sawaya; M Nakajima; L A Liotta; G L Nicolson; W G Stetler-Stevenson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.